![Elizabeth Stoner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Stoner
Directeur/Membre du Conseil chez
IBIO, INC.
Fortune : 82 595 $ au 31/08/2026
Profil
Dr. Elizabeth Stoner, MD, is an Independent Director at iBio, Inc., a Director & Chief Development Officer at Vascular Pharmaceuticals, Inc., an Entrepreneur Partner at MPM BioImpact LLC and a Member-Governors Board at Albert Einstein College of Medicine, Inc. She is on the Board of Directors at iBio, Inc., Antiva Biosciences, Inc., LIB Therapeutics LLC and Vascular Pharmaceuticals, Inc. Dr. Stoner was previously employed as a Chairman by Arovella Therapeutics Ltd., a Chief Executive Officer by Semma Therapeutics, Inc., an Independent Director by Radius Health, Inc., a Chief Medical & Development Officer by Rhythm Pharmaceuticals, Inc., a Chief Development Officer by Allergan GI Corp., an Independent Director by Momenta Pharmaceuticals, Inc., a Senior VP-Clinical Sciences & Product Development by Merck & Co., Inc., a SVP-Global Clinical Development Operations by Merck Research Laboratories Massachusetts LLC, a Chief Medical Officer by ViraCyte LLC, and an Assistant Professor by Weill Cornell Medical College.
She also served on the board at Metabasis Therapeutics, Inc. and Triplet Therapeutics, Inc. She received her undergraduate degree from Ottawa University (Kansas), a graduate degree from Stony Brook University and a doctorate degree from Albert Einstein College of Medicine, Inc..
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/11/2025 | 1 920 804 ( 0,16% ) | 82 595 $ | 31/08/2026 | |
IBIO, INC. -.--% | 01/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Elizabeth Stoner
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 07/05/2026 |
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company dedicated to bringing novel, highly effective and safe therapies for cardiovascular disease | Directeur/Membre du Conseil | 01/01/2016 |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2007 |
Vascular Pharmaceuticals, Inc.
 Vascular Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical therapies for diabetic complications | Directeur/Membre du Conseil | 01/09/2012 |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Elizabeth Stoner
| Sociétés | Poste | Fin |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Président | 09/02/2026 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2020 |
| ALLOVIRPAR | Directeur Technique/Scientifique/R&D | 01/04/2019 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Elizabeth Stoner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ottawa University (Kansas)
 Ottawa University (Kansas) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical therapies for diabetic complications | Health Technology |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company dedicated to bringing novel, highly effective and safe therapies for cardiovascular disease | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
